ISRCTN85948357已完成不适用
Combined treatment with thyroxine plus triiodothyronine for primary hypothyroidism in humans
Hospital Ramón y Cajal, Madrid (Spain)0 个研究点目标入组 0 人开始时间: 2005年7月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •Inclusion criteria required women between 18 and 70 years-old, presenting with overt primary hypothyroidism as defined by increased thyroid-stimulating hormone (TSH) and decreased free T4 serum levels at diagnosis, who maintained serum TSH levels within the normal range on a stable levothyroxine dose of 100 µg per day for at least the previous year.
排除标准
- •Exclusion criteria included mental illnesses, affective disorders or use of psychotropic drugs, cardiovascular, renal or hepatic disease, osteoporosis, and treatment with drugs that may interfere with thyroid function other than levothyroxine.
- •The external euthyroid control group was composed of healthy women.
研究者
相似试验
进行中（未招募）
不适用
Triiodothyronine as an adjunct in treatment of acute schizophreniaAcute Schizoprenia episodeMedDRA version: 9.1Level: LLTClassification code 10001065Term: Acute schizophrenia episodeEUCTR2007-001541-18-LTInstitute of Psychophysiology and Rehabilitation (IRP) of the Kaunas University of Medicine60
进行中（未招募）
不适用
Triiodothyronine as an adjunct to accelerate the antidepressant effects of the selective serotonin reuptake inhibitor (SSRI) escitalopramDepressive episodeMedDRA version: 9.1Level: LLTClassification code 10012402Term: Depressive episodeEUCTR2007-001540-45-LTInstitute of Psychophysiology and Rehabilitation (IRP) of the Kaunas University of Medicine60
进行中（未招募）
1 期
Triiodothyronine for the treatment of critically ill patients with COVID-19 infection (Thy-Support Study)ICU patients diagnosed with pulmonary infection due to COVID-19 and require mechanical respiratory support or ECMOMedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001623-13-GRni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.60
进行中（未招募）
1 期
In patients who have no more thyroid, the combination of two hormones (T3 and T4) normally secreted by thyroid will be studied, in order to evaluate their effects at the periphery. Neither doctors or patients will know if the patient is enrolled in the group treated with both hormones or in the one treated with only T4 plus a placebo.Post-surgical hypothyroidism in substitutive therapyMedDRA version: 20.0Level: LLTClassification code 10036429Term: Postsurgical hypothyroidismSystem Organ Class: 100000004863EUCTR2016-000687-41-ITAZIENDA UNITÀ SANITARIA LOCALE DI MODENA260
招募中
不适用
Combination Therapy with Tiotropium in Chronic Obstructive Pulmonary Disease (COTTS)ACTRN12608000079347Centre for Clinical Research and effective practice (CCRep)40